Combination of Linear Accelerator–Based Intensity-Modulated Total Marrow Irradiation and Myeloablative Fludarabine/Busulfan: A Phase I Study
Open Access
- 1 December 2014
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 20 (12) , 2034-2041
Abstract
No abstract availableKeywords
Funding Information
- Otsuka Pharmaceuticals
- Varian Medical Systems Inc.
This publication has 44 references indexed in Scilit:
- Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapiesBlood, 2012
- Multivariable Model for Time to First Treatment in Patients With Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2011
- Minimal Residual Disease following Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2011
- Reduced Mortality after Allogeneic Hematopoietic-Cell TransplantationNew England Journal of Medicine, 2010
- NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell TransplantationTransplantation and Cellular Therapy, 2010
- NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biological Considerations of Hematological Relapse following Allogeneic Stem Cell Transplantation Unrelated to Graft-versus-Tumor Effects: State of the ScienceTransplantation and Cellular Therapy, 2010
- NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia ReactionTransplantation and Cellular Therapy, 2010
- Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete RemissionJAMA, 2009
- Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar timeBone Marrow Transplantation, 2005
- A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcomeBlood, 2004